$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000112414024000069 Filed on July 31, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$708.7M	$699.3M
YoY Change	12.78%	12.41%
Cost Of Revenue	$196.1M	$189.8M
YoY Change	16.34%	20.93%
Gross Profit	$512.6M	$509.4M
YoY Change	11.48%	9.53%
Gross Profit Margin	72.33%	72.85%
Selling, General & Admin	$411.9M	$387.1M
YoY Change	5.45%	-6.59%
% of Gross Profit	80.35%	75.99%
Research & Development	$100.1M	$120.9M
YoY Change	-10.18%	16.13%
% of Gross Profit	19.53%	23.73%
Depreciation & Amortization	$30.30M	$29.70M
YoY Change	3.41%	-41.12%
% of Gross Profit	5.91%	5.83%
Operating Expenses	$512.0M	$508.0M
YoY Change	1.98%	-6.18%
Operating Profit	-$39.40M	-$26.26M
YoY Change	-675.31%	-65.62%
Interest Expense	$1.975M	$1.658M
YoY Change	-134.05%	-155.45%
% of Operating Profit
Other Income/Expense, Net	$1.975M	$11.91M
YoY Change	-134.02%	-498.39%
Pretax Income	-$37.43M	-$14.35M
YoY Change	-3688.49%	-82.05%
Income Tax	$800.0K	$1.463M
% Of Pretax Income
Net Earnings	-$38.24M	-$15.81M
YoY Change	-4915.62%	-80.49%
Net Earnings / Revenue	-5.4%	-2.26%
Basic Earnings Per Share	-$0.21	-$0.09
Diluted Earnings Per Share	-$0.21	-$0.09
COMMON SHARES
Basic Shares Outstanding	184.8M shares	184.5M shares
Diluted Shares Outstanding	184.8M shares	184.3M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.021B	$946.8M
YoY Change	39.04%	22.05%
Cash & Equivalents	$588.8M	$530.2M
Short-Term Investments	$432.3M	$416.6M
Other Short-Term Assets	$110.2M	$114.5M
YoY Change	35.19%	28.43%
Inventory	$137.0M	$127.4M
Prepaid Expenses
Receivables	$264.8M	$263.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.533B	$1.452B
YoY Change	33.53%	23.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$690.3M	$703.1M
YoY Change	-0.3%	-16.91%
Goodwill	$2.367B	$2.367B
YoY Change	0.04%	0.88%
Intangibles	$1.864B	$1.843B
YoY Change	-2.56%	-3.51%
Long-Term Investments
YoY Change
Other Assets	$170.8M	$167.5M
YoY Change	13.32%	112.97%
Total Long-Term Assets	$5.215B	$5.221B
YoY Change	-1.08%	0.76%
TOTAL ASSETS
Total Short-Term Assets	$1.533B	$1.452B
Total Long-Term Assets	$5.215B	$5.221B
Total Assets	$6.749B	$6.673B
YoY Change	5.1%	5.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$97.65M	$52.98M
YoY Change	32.76%	-29.44%
Accrued Expenses	$314.0M	$302.5M
YoY Change	1.33%	-8.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$249.0M	$256.2M
YoY Change	358.63%	376.25%
Total Short-Term Liabilities	$723.7M	$668.6M
YoY Change	51.87%	37.0%
LONG-TERM LIABILITIES
Long-Term Debt	$2.334B	$2.333B
YoY Change	0.56%	0.59%
Other Long-Term Liabilities	$332.2M	$326.7M
YoY Change	-2.8%	-33.55%
Total Long-Term Liabilities	$332.2M	$326.7M
YoY Change	-2.8%	-88.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$723.7M	$668.6M
Total Long-Term Liabilities	$332.2M	$326.7M
Total Liabilities	$3.538B	$3.481B
YoY Change	7.23%	5.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.633B	-$3.595B
YoY Change	6.26%	5.12%
Common Stock	$6.839B	$6.789B
YoY Change	4.54%	4.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.211B	$3.192B
YoY Change
Total Liabilities & Shareholders Equity	$6.749B	$6.673B
YoY Change	5.1%	5.0%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$38.24M	-$15.81M
YoY Change	-4915.62%	-80.49%
Depreciation, Depletion And Amortization	$30.30M	$29.70M
YoY Change	3.41%	-41.12%
Cash From Operating Activities	$138.7M	$107.1M
YoY Change	468.52%	6.61%
INVESTING ACTIVITIES
Capital Expenditures	$71.16M	$35.87M
YoY Change	182.37%	3.3%
Acquisitions
YoY Change
Other Investing Activities	-$10.56M	-$111.3M
YoY Change	35.36%	-209.95%
Cash From Investing Activities	-$81.72M	-$147.1M
YoY Change	147.62%	-321.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-226.0K	224.6M
YoY Change	-326.0%	1300.18%
NET CHANGE
Cash From Operating Activities	138.7M	107.1M
Cash From Investing Activities	-81.72M	-147.1M
Cash From Financing Activities	-226.0K	224.6M
Net Change In Cash	56.78M	184.5M
YoY Change	-767.96%	0.87%
FREE CASH FLOW
Cash From Operating Activities	$138.7M	$107.1M
Capital Expenditures	$71.16M	$35.87M
Free Cash Flow	$67.56M	$71.20M
YoY Change	-8545.12%	8.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	184313000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	180204000	shares
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	622093000	usd
	us-gaap	Depreciation Depreciation	54300000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	388000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2367120000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	exas	Changes In Fair Value ChangesInFairValue	-343000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4200000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	699264000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	622093000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1336788000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1224543000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1100000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2800000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	19100000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	17300000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	40100000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	36400000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	60901000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20492000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12531000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	183332000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	179393000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3043162000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	964000	usd
CY2023Q1	exas	Compensation Expense Related To Issuance Of Stock Options And Restricted Stock Awards Values CompensationExpenseRelatedToIssuanceOfStockOptionsAndRestrictedStockAwardsValues	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	35077000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	49139000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-74151000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3517000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3057708000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	852000	usd
CY2023Q2	exas	Compensation Expense Related To Issuance Of Stock Options And Restricted Stock Awards Values CompensationExpenseRelatedToIssuanceOfStockOptionsAndRestrictedStockAwardsValues	0	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	23000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	61725000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	16344000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-81026000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	996000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3056622000	usd
	us-gaap	Profit Loss ProfitLoss	-126036000	usd
	us-gaap	Profit Loss ProfitLoss	-155177000	usd
	us-gaap	Depreciation Depreciation	60319000	usd
	us-gaap	Depreciation Depreciation	54325000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1115000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-4741000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2225000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	672000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	116925000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	110864000	usd
	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	10254000	usd
	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	10324000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46622000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45857000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	12598000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	621000	usd
	exas	Gain Loss On Contingent Consideration From Disposition Of Asset GainLossOnContingentConsiderationFromDispositionOfAsset	3532000	usd
	exas	Gain Loss On Contingent Consideration From Disposition Of Asset GainLossOnContingentConsiderationFromDispositionOfAsset	0	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7636000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4687000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	14042000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	13777000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2667000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3965000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-96000	usd
	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-12957000	usd
	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-12766000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-17865000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48754000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2719000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	9624000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	9941000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4234000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24754000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	62209000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	324372000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	50656000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	80335000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	270825000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	73515000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64081000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	810000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	6173000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	205000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-318567000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	149415000	usd
	exas	Proceeds From Exercise Of Common Stock Options Net Of Cash Paid For Taxes ProceedsFromExerciseOfCommonStockOptionsNetOfCashPaidForTaxes	-1365000	usd
	exas	Proceeds From Exercise Of Common Stock Options Net Of Cash Paid For Taxes ProceedsFromExerciseOfCommonStockOptionsNetOfCashPaidForTaxes	1816000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	19402000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	16344000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	266750000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	137976000	usd
	us-gaap	Repayments Of Accounts Receivable Securitization RepaymentsOfAccountsReceivableSecuritization	50000000	usd
	us-gaap	Repayments Of Accounts Receivable Securitization RepaymentsOfAccountsReceivableSecuritization	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-13186000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6499000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	221601000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	149637000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1446000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	609000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-73658000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	361870000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	609675000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	242790000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	536017000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	604660000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	12442000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	7850000	usd
	us-gaap	Interest Paid Net InterestPaidNet	11971000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7385000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530180000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	604363000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	5837000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	297000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	536017000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	604660000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company’s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, contingent consideration, and accounting for income taxes. The Company’s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q and the 2023 Form 10-K.</span></div>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	37539000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32756000	shares
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	699264000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1336788000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1224543000	usd
	exas	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price As A Percentage Of Revenue ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPriceAsAPercentageOfRevenue	-0.01
	exas	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price As A Percentage Of Revenue ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPriceAsAPercentageOfRevenue	0.02
CY2024Q2	us-gaap	Cash Cash	519836000	usd
CY2023Q4	us-gaap	Cash Cash	530100000	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	10344000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	75278000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530180000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	605378000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2331000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	3841000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	416602000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	172266000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	946782000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	777644000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	425486000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	184000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1055000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	424615000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	243649000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	406000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	352000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	243703000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	176531000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	176311000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	248955000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	248304000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	292510000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	897000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	15165000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	158000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	307675000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1055000	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	52363000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	58593000	usd
CY2024Q2	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	75010000	usd
CY2023Q4	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	68882000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	127373000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	127475000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1173983000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1115557000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	470900000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	417203000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	703083000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	698354000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	29700000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	27500000	usd
	us-gaap	Depreciation Depreciation	60300000	usd
CY2024Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	100700000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1006894000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	413416000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	593478000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2024Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2256894000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	413416000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1843478000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1007331000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	366935000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	640396000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2257331000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	366935000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1890396000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	46288000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	91860000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	90800000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	90800000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	90800000	usd
CY2024Q2	exas	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	182930000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	593478000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2346040000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-353000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2366972000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Security Owned Not Readily Marketable Fair Value SecurityOwnedNotReadilyMarketableFairValue	7650000	usd
	exas	Settlement Of Non Marketable Securities SettlementOfNonMarketableSecurities	-6250000	usd
CY2024Q2	us-gaap	Security Owned Not Readily Marketable Fair Value SecurityOwnedNotReadilyMarketableFairValue	1057000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	277900000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	288700000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	19000000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	258900000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	288657000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7636000	usd
	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	3100000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	277921000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4700000	usd
CY2024Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount	5102000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount	779000	usd
CY2024Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	15071000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	12528000	usd
CY2024Q2	us-gaap	Other Investment Not Readily Marketable Fair Value OtherInvestmentNotReadilyMarketableFairValue	52227000	usd
CY2023Q2	us-gaap	Other Investment Not Readily Marketable Fair Value OtherInvestmentNotReadilyMarketableFairValue	34197000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17700000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10300000	usd
	exas	Principal Amount Convertible Note PrincipalAmountConvertibleNote	1000	usd
	exas	Debt Instrument Repurchase Price Due To Change In Control As Percentage Of Principal Amount DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount	100
CY2024Q2	us-gaap	Share Price SharePrice	42.25
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1316000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1315000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2631000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2692000	usd
CY2024Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	264000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	25000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	289000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	56000	usd
CY2024Q2	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	10254000	usd
CY2023Q2	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	0	usd
	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	10254000	usd
	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	10324000	usd
CY2024Q2	exas	Coupon Interest Expense CouponInterestExpense	6863000	usd
CY2023Q2	exas	Coupon Interest Expense CouponInterestExpense	4906000	usd
	exas	Coupon Interest Expense CouponInterestExpense	11770000	usd
	exas	Coupon Interest Expense CouponInterestExpense	8260000	usd
CY2024Q2	exas	Interest Expense Income Debt InterestExpenseIncomeDebt	-1811000	usd
CY2023Q2	exas	Interest Expense Income Debt InterestExpenseIncomeDebt	6246000	usd
	exas	Interest Expense Income Debt InterestExpenseIncomeDebt	4436000	usd
	exas	Interest Expense Income Debt InterestExpenseIncomeDebt	684000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-2430000	usd
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-59000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-2371000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	1660000	usd
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-2853000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	4513000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56600000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	61700000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	116900000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110900000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0530
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0530
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.6313
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.6313
	us-gaap	Operating Lease Payments OperatingLeasePayments	19188000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	19093000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	612000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	342000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3025000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1561000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	18925000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5375000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	13717000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2670000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y8M23D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M15D
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y14D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0655
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0641
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0678
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0703
	exas	Operating Lease Right Of Use Asset Modification OperatingLeaseRightOfUseAssetModification	8600000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	139800000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	143700000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	194800000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	27100000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	167700000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	190400000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29400000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	161100000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	21400000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	11300000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	22300000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7300000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15000000.0	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	11900000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4400000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7500000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	45200000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	24100000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	21100000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	41700000	usd
CY2023Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	31600000	usd
CY2024Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	31600000	usd

Files In Submission

Name	View Source	Status
0001124140-24-000069-index-headers.html	Edgar Link	pending
0001124140-24-000069-index.html	Edgar Link	pending
0001124140-24-000069.txt	Edgar Link	pending
0001124140-24-000069-xbrl.zip	Edgar Link	pending
exas-20240630.htm	Edgar Link	pending
exas-20240630.xsd	Edgar Link	pending
exas-20240630xexx311.htm	Edgar Link	pending
exas-20240630xexx312.htm	Edgar Link	pending
exas-20240630xexx321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
exas-20240630_cal.xml	Edgar Link	unprocessable
exas-20240630_def.xml	Edgar Link	unprocessable
exas-20240630_lab.xml	Edgar Link	unprocessable
exas-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
exas-20240630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2024 Q3 Form 10-Q Financial Statement

#000112414024000069 Filed on July 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2024 Q3 Form 10-Q Financial Statement

#000112414024000069 Filed on July 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas